Search Results

There are 42886 results for: content related to: Long-term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen-negative chronic hepatitis B in Taiwan

  1. Abstract of Papers Submitted to the American Association of the Study of Liver Disease

    Hepatology

    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  2. Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy

    Journal of Viral Hepatitis

    Volume 12, Issue 3, May 2005, Pages: 251–261, Y. Tanabe, K. Nagayama, N. Enomoto, N. Izumi, J. Tazawa, M. Kurosaki, N. Sakamoto, C. Sato and M. Watanabe

    Version of Record online : 10 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00511.x

  3. Abstracts of papers submitted to the american association for the study of liver diseases

    Hepatology

    Volume 18, Issue S7, October 1993, Pages: 57A–346A,

    Version of Record online : 12 DEC 2005, DOI: 10.1002/hep.1840180703

  4. Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection

    Journal of Viral Hepatitis

    Volume 8, Issue 6, November 2001, Pages: 421–429, K. Yoshioka, M. Kobayashi, E. Orito, K. Watanabe, M. Yano, Y. Sameshima, A. Kusakabe, H. Hirofuji, A. Fuji, J. Kuriki, M. Arao, K. Murase, M. Mizokami, S. Kakumu and the IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine

    Version of Record online : 16 JAN 2002, DOI: 10.1046/j.1365-2893.2001.00323.x

  5. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy

    Journal of Gastroenterology and Hepatology

    Volume 21, Issue 1, January 2006 , Pages: 281–287, Hideaki Taniguchi, Yoshiaki Iwasaki, Akiko Fujiwara, Kohsaku Sakaguchi, Akio Moriya, Piao Cheng Yu, Akinobu Takaki, Shin-Ichi Fujioka, Hiroyuki Shimomura and Yasushi Shiratori

    Version of Record online : 6 FEB 2006, DOI: 10.1111/j.1440-1746.2006.04201.x

  6. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy

    Liver International

    Volume 25, Issue 1, February 2005, Pages: 85–90, Mitsuhiko Moriyama, Hiroshi Matsumura, Hiroshi Aoki, Toshihiro Shimizu, Hiroaki Yamagami, Atsuo Shioda, Miki Kaneko, Iori Goto, Naohide Tanaka and Yasuyuki Arakawa

    Version of Record online : 7 FEB 2005, DOI: 10.1111/j.1478-3231.2005.01028.x

  7. Analysis of hepatocellular carcinoma tumor growth detected in sustained responders to interferon in patients with chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 16, Issue 10, October 2001, Pages: 1131–1137, Hidenori Toyoda, Takashi Kumada, Takashi Honda, Kazuhiko Hayashi, Yoshiaki Katano, Isao Nakano, Tetsuo Hayakawa and Yoshihide Fukuda

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1440-1746.2001.02595.x

  8. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  9. Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 15, Issue s2, May 2000, Pages: E134–E140, Masao Omata and Yasushi Shiratori

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1440-1746.2000.02115.x

  10. You have free access to this content
    IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

    Clinical & Experimental Immunology

    Volume 126, Issue 1, October 2001, Pages: 92–100, M. Hirayama, T. Maruyama, H. Mitsui, H. Maekawa, H. Yamada, N. Hashimoto, K. Koike, S. Kimura, K. Yasuda, S. Iino and J. Green

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1365-2249.2001.01648.x

  11. You have free access to this content
    Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

    Liver Transplantation

    Volume 10, Issue 7, July 2004, Pages: 850–858, R. Todd Stravitz, Mitchell L. Shiffman, Arun J. Sanyal, Velimir A. Luketic, Richard K. Sterling, Douglas M. Heuman, April Ashworth, A. Scott Mills, Melissa Contos, Adrian H. Cotterell, Daniel Maluf, Marc P. Posner and Robert A. Fisher

    Version of Record online : 29 JUN 2004, DOI: 10.1002/lt.20189

  12. Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection

    European Journal of Clinical Investigation

    Volume 38, Issue 6, June 2008, Pages: 421–429, T. Reiberger, S. Rasoul-Rockenschaub, A. Rieger, P. Ferenci, A. Gangl and M. Peck-Radosavljevic

    Version of Record online : 16 MAY 2008, DOI: 10.1111/j.1365-2362.2008.01958.x

  13. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 383–392, Yuko Arima, Naoto Kawabe, Senju Hashimoto, Masao Harata, Yoshifumi Nitta, Michihito Murao, Takuji Nakano, Hiroaki Shimazaki, Kyoko Kobayashi, Naohiro Ichino, Keisuke Osakabe, Toru Nishikawa, Akihiko Okumura, Tetsuya Ishikawa and Kentaro Yoshioka

    Version of Record online : 4 MAR 2010, DOI: 10.1111/j.1872-034X.2009.00618.x

  14. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  15. Upregulation of iron regulatory hormone hepcidin by interferon α

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 387–394, Kazuhiko Ichiki, Katsuya Ikuta, Lynda Addo, Hiroki Tanaka, Yusuke Sasaki, Yasushi Shimonaka, Katsunori Sasaki, Satoshi Ito, Motohiro Shindo, Takaaki Ohtake, Mikihiro Fujiya, Yoshihiro Torimoto and Yutaka Kohgo

    Version of Record online : 27 JAN 2014, DOI: 10.1111/jgh.12348

  16. Quantifying serotonin transporters by PET with [11C]-DASB before and after interferon-α treatment

    Synapse

    Volume 68, Issue 11, November 2014, Pages: 548–555, Peter A. Shapiro, Richard P. Sloan, Chetram Deochand, Ana M. Franceschi, Christine Delorenzo, J. John Mann and Ramin V. Parsey

    Version of Record online : 4 AUG 2014, DOI: 10.1002/syn.21766

  17. Interferon-α2a for chronic hepatitis B with e antigen or antibody: comparable antiviral effects on wild-type virus and precore mutant

    Journal of Viral Hepatitis

    Volume 2, Issue 5, September 1995, Pages: 243–250, T. Aikawa, K. Kanai, M. Kako, T. Kawasaki, K. Hino, S. Iwabuchi, H. Tsubouchi, Y. Takehira, F. Tsuda, H. Okamoto, Y. Miyakawa and M. Mayumi

    Version of Record online : 18 DEC 2007, DOI: 10.1111/j.1365-2893.1995.tb00036.x

  18. Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon

    Journal of Gastroenterology and Hepatology

    Volume 16, Issue 9, September 2001, Pages: 1015–1021, Hiroshi Kojima, Yasushi Hongo, Hideharu Harada, Toshihiro Inoue, Katsuhiko Miyaji, Motomi Kashiwagi, Tetsuya Momose, Yoshifumi Arisaka, Hideo Fukui, Seiyo Murai, Hajime Tokita, Hiroshi Kamitsukasa, Michiyasu Yagura and Kenichi Katsu

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1440-1746.2001.02569.x

  19. Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-α therapy for patients with chronic hepatitis C

    Liver International

    Volume 25, Issue 2, April 2005, Pages: 247–253, Izumi Hasegawa, Etsuro Orito, Yasuhito Tanaka, Noboru Hirashima, Kenji Sakakibara, Mayumi Sakurai, Seiji Suzuki, Fuminaka Sugauchi, Tomoyoshi Ohno, Ryuzo Ueda and Masashi Mizokami

    Version of Record online : 17 MAR 2005, DOI: 10.1111/j.1478-3231.2005.1096.x

  20. Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 2, March 2005, Pages: 186–191, A. Marrone, R. Zampino, G. Portella, M. Grimaldi, E. D. Mangoni, L. Santarpia, G. Ruggiero and R. Utili

    Version of Record online : 9 FEB 2005, DOI: 10.1111/j.1365-2893.2005.00619.x

    Corrected by:

    Corrigenda

    Vol. 15, Issue 2, 156, Version of Record online: 31 DEC 2007